Sacha Inchi Oil.

Sacha inchi oil is roughly half alpha-linolenic acid, with three double bonds that oxidise easily. Tocopherols interrupt the lipid peroxidation chain, which is why they accompany this oil class as a matter of formulation practice.

Once tocopherol has quenched a lipid radical it needs an electron to return to its active state. Ascorbate supplies that electron at the lipid water boundary, keeping the protection on a polyunsaturated oil going for longer.

Converting alpha-linolenic acid onward to longer chain omega-3 depends on delta-6 desaturase, an enzyme whose activity falls when zinc status is low. Adequate zinc keeps that conversion step working.

B6 status affects the desaturase and elongase steps that carry alpha-linolenic acid toward EPA. Supplying the plant omega-3 without the cofactors leaves that conversion limited.

Evening primrose linoleic acid and sacha inchi alpha-linolenic acid are processed by the same delta-6 desaturase. A heavy omega-6 load occupies that enzyme and lowers how much plant omega-3 moves onward.

Borage supplies gamma-linolenic acid downstream of delta-6 desaturase, and its linoleic acid content competes for that same enzyme with alpha-linolenic acid. The two oils therefore interact at a single shared bottleneck.

Human conversion of alpha-linolenic acid to DHA is limited, so a plant oil alone leaves that end of the chain thin. Algal DHA supplies the long-chain product directly while sacha inchi covers the shorter chain fatty acid.

Vitamin D3 uptake depends on micelle formation, which requires dietary fat and the bile release it triggers. An accompanying oil provides that condition.

Alpha-linolenic acid from sacha inchi and linoleic acid from common seed oils are handled by the same delta-6 desaturase and the same elongase. Raising linoleic acid intake lowers the fraction of ALA that proceeds toward EPA. This is why the ratio of the two fats in a formula, and in the wider diet, changes what the same ALA dose does.

Conversion of ALA to EPA in humans is limited and variable, and conversion onward to DHA is more limited still. Supplying preformed EPA alongside a plant ALA source bypasses the desaturase bottleneck rather than competing with it. The two therefore cover different positions in one pathway.

A plant oil contributes the omega-3 precursor while a marine oil contributes the long-chain products directly. Because the desaturase step is rate-limiting, preformed EPA and DHA raise long-chain omega-3 status by a route that ALA conversion does not reliably achieve. Formulas that pair them are covering the precursor and the product, not doubling the same input.

Both oils are dominated by alpha-linolenic acid and enter the same desaturation and elongation route. Combining them changes total ALA supply and the accompanying linoleic acid load, since the two oils differ in their omega-6 fraction. There is no mechanistic advantage to the pair beyond total ALA and sensory or stability handling.

GLA is the product of delta-6 desaturation of linoleic acid, so supplying it directly removes one competitive demand on the enzyme that ALA also needs. The practical result of pairing a preformed GLA source with an ALA-rich oil is a shifted balance of downstream omega-6 and omega-3 products. The direction is mechanistically clear; the magnitude in people is not settled.

Vitamin E requirement scales with the amount of polyunsaturated fat in the diet, because tocopherols and tocotrienols are the chain-breaking antioxidants that interrupt lipid peroxidation. Sacha inchi oil is highly unsaturated and carries its own tocopherols, and formulators commonly add more. This is oxidative protection of the oil and of membrane lipids, stated as chemistry.

Carnosic acid and related rosemary diterpenes are used to slow peroxide formation in unsaturated oils during processing and shelf life. Sacha inchi oil oxidises readily, which is the reason the pairing exists. The role is product stability rather than a physiological effect.

Astaxanthin sits in the lipid phase and quenches radicals and singlet oxygen where polyunsaturated fatty acids are most vulnerable. Pairing it with a highly unsaturated oil is the same logic as adding tocopherol, from a different chemistry. No combination trial defines a ratio.

Glutathione peroxidase 4 reduces lipid hydroperoxides within membranes and requires selenium at its active site. A diet richer in polyunsaturated fat raises the load on that enzyme. Adequate selenium is therefore the enzymatic counterpart to the tocopherol side of lipid protection.

Glutathione peroxidase consumes reduced glutathione when it disposes of lipid hydroperoxides, and cysteine availability limits glutathione synthesis. That places a cysteine donor upstream of the system handling peroxidised polyunsaturated fat. Mechanistic pairing; not an outcome measured with this oil.

Dietary triacylglycerols are absorbed only after pancreatic lipase and colipase hydrolyse them to free fatty acids and monoacylglycerols. Sacha inchi oil is supplied as a triacylglycerol, so it depends on that step. Adding lipase is relevant where lipolytic capacity is the limiting factor.

Bile salts emulsify dietary fat and form the mixed micelles that carry fatty acids and monoacylglycerols to the brush border. Where bile flow is low, fat absorption falls whatever the oil. This is why bile components appear in formulas built around lipid delivery.

Retinyl esters and carotenoids need dietary fat to be incorporated into mixed micelles and then into chylomicrons. A long-chain triacylglycerol oil provides exactly that vehicle. The effect belongs to the fat, not to sacha inchi specifically.

Menaquinone-7 is lipophilic and its uptake improves when it is taken with fat, which is why it is commonly dissolved in an oil in softgels. Sacha inchi oil serves as that carrier. The mechanism is vehicle chemistry rather than a specific interaction between the two molecules.

Xanthophyll absorption rises when the carotenoid is delivered in a lipid phase that supports micelle formation. An unsaturated long-chain oil is a standard vehicle for that purpose. The oil is the delivery matrix, not an active partner.

Curcuminoids are poorly soluble in water and are handled better when presented in a lipid phase. Suspending them in a triacylglycerol oil is one of the routine formulation answers. The change belongs to the lipid vehicle, so any oil of similar chain length behaves comparably.

Phospholipids reduce interfacial tension and keep an oil dispersed in an aqueous matrix, which is what makes emulsions, powders and beverage formats possible. Sacha inchi oil is emulsified this way for microencapsulation. The role is physical, not physiological.

Medium-chain triacylglycerols are hydrolysed faster and enter portal circulation directly, while the long-chain fatty acids of sacha inchi oil are packaged into chylomicrons. Blending them changes the digestion and transport profile of the fat in a formula. The blend is a delivery decision, and neither route is a substitute for the other.

The desaturation and elongation of alpha-linolenic acid depends on a small set of nutrient cofactors, magnesium among them. Where those cofactors are short, the same ALA intake yields less downstream product. The relationship is a cofactor one; no combination study quantifies it with this oil.

Samrit and colleagues gave cold-pressed sacha inchi oil to rats and reported shifts in gut microbial composition. That is an animal finding about composition, not a human outcome and not a demonstrated benefit of co-supplementation. It is enough to justify the pairing as a question, not as an established interaction.